Brain polar phenol content, behavioural and neurochemical effects of Corinthian currant in a rotenone rat model of Parkinson’s disease

ABSTRACT Objective Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of nigral dopaminergic neurons, leading to reduced motor control. A contributing factor for the nigrostriatal degeneration is known to be oxidative stress, while antioxidant/anti-inflammatory properties of natural polyphenols have been suggested to show beneficial effects. The present study questioned the potential neuroprotective effects of supplementary diet with Corinthian currant, using a rat rotenone PD model. Methods The alterations in motor activity, brain Corinthian currant polar phenols’ accumulation, expression patterns of tyrosine hydroxylase (TH), dopamine transporter (DAT) and brain-derived neurotrophic factor (BDNF) in the nigrostriatal dopaminergic system were determined in rotenone-treated, currant-diet rats and matching controls. Results Rotenone treatment resulted in motor deficits and TH expression decreases in the nigrostriatal pathway, exhibiting PD-like behavioural motor and neurochemical phenotypes. Interestingly, 38 days Corinthian currant consumption resulted in differential accumulation of polar phenols in mesencephalon and striatum and had a significant effect on attenuating motor deficits and dopaminergic cell loss in substantia nigra pars compacta. In addition, it induced up-regulation of BDNF expression in the nigrostriatal dopaminergic system. Discussion Taken all together, evidence is provided for the potential neuroprotective influences of Corinthian currant consumption, involving the neurotrophic factor BDNF, in rescuing aspects of PD-like phenotype.

[1]  Chunyan Li,et al.  Ginsenoside Rg3 exerts a neuroprotective effect in rotenone-induced Parkinson's disease mice via its anti-oxidative properties. , 2021, European journal of pharmacology.

[2]  Tsu-Kung Lin,et al.  Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease , 2021, Biomedicines.

[3]  A. Chiou,et al.  Mechanistic insight into the capacity of natural polar phenolic compounds to abolish Alzheimer's disease-associated pathogenic effects of apoE4 forms. , 2021, Free radical biology & medicine.

[4]  C. Derosier,et al.  Metabolic and neurological consequences of the treatment with polyphenols: a systematic review in rodent models of noncommunicable diseases , 2021, Nutritional neuroscience.

[5]  D. Banji,et al.  Neuroprotective Effect of Turmeric Extract in Combination with Its Essential Oil and Enhanced Brain Bioavailability in an Animal Model , 2021, BioMed research international.

[6]  R. Mensink,et al.  Effects of nutritional interventions on BDNF concentrations in humans: a systematic review , 2021, Nutritional neuroscience.

[7]  D. Choi,et al.  Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease , 2020, Journal of Chemical Neuroanatomy.

[8]  J. Weber,et al.  The Pathology of Parkinson’s Disease and Potential Benefit of Dietary Polyphenols , 2020, Molecules.

[9]  W. L. Lim,et al.  Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress. , 2020, Current drug targets.

[10]  G. Wegener,et al.  Ketamine-induced regulation of TrkB-GSK3β signaling is accompanied by slow EEG oscillations and sedation but is independent of hydroxynorketamine metabolites , 2019, Neuropharmacology.

[11]  M. Lévesque,et al.  Neuroprotective benefits of grape seed and skin extract in a mouse model of Parkinson’s disease , 2019, Nutritional neuroscience.

[12]  Xin-Fu Zhou,et al.  The effects of rotenone on TH, BDNF and BDNF-related proteins in the brain and periphery: Relevance to early Parkinson’s disease , 2019, Journal of Chemical Neuroanatomy.

[13]  R. V. van Rijn,et al.  Commonly Used Anesthesia/Euthanasia Methods for Brain Collection Differentially Impact MAPK Activity in Male and Female C57BL/6 Mice , 2019, Front. Cell. Neurosci..

[14]  J. Jodynis-Liebert,et al.  Polyphenols in Parkinson’s Disease: A Systematic Review of In Vivo Studies , 2018, Nutrients.

[15]  E. Natsaridis,et al.  Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain , 2018, Neuropharmacology.

[16]  A. Sureda,et al.  Regulation of autophagy by polyphenols: Paving the road for treatment of neurodegeneration. , 2017, Biotechnology advances.

[17]  S. Salimi,et al.  The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson’s disease in rat , 2018, Metabolic Brain Disease.

[18]  N. Medlicott,et al.  Acute low-dose ketamine produces a rapid and robust increase in plasma BDNF without altering brain BDNF concentrations , 2018, Drug Delivery and Translational Research.

[19]  Junxia Xie,et al.  Neuroprotective effect of resveratrol on rotenone-treated C57BL/6 mice , 2017, Neuroreport.

[20]  A. Kanthasamy,et al.  Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease , 2017, Journal of neurochemistry.

[21]  G. O’Keeffe,et al.  Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysis. , 2017, Parkinsonism & related disorders.

[22]  F. Ahmad,et al.  Quantification of rutin in rat's brain by UHPLC/ESI-Q-TOF-MS/MS after intranasal administration of rutin loaded chitosan nanoparticles , 2016, EXCLI journal.

[23]  J. Raymick,et al.  Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-l-carnitine , 2015, Neuroscience Letters.

[24]  D. Pal,et al.  Free radicals, natural antioxidants, and their reaction mechanisms , 2015 .

[25]  Joachim K. Krauss,et al.  The rotenone-induced rat model of Parkinson's disease: Behavioral and electrophysiological findings , 2015, Behavioural Brain Research.

[26]  S. Sathaye,et al.  Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice , 2014, Neuropharmacology.

[27]  C. Ferris,et al.  A phenotypic model recapitulating the neuropathology of Parkinson's disease , 2013, Brain and behavior.

[28]  S. Karuppagounder,et al.  Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats , 2013, Neuroscience.

[29]  R. Lazzaroni,et al.  Free radical scavenging by natural polyphenols: atom versus electron transfer. , 2013, The journal of physical chemistry. A.

[30]  Chengbiao Wu,et al.  Current advances in using neurotrophic factors to treat neurodegenerative disorders , 2012, Translational Neurodegeneration.

[31]  Chunnuan Chen,et al.  Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models , 2012, Critical reviews in toxicology.

[32]  E. Beltrão,et al.  Differential vulnerability of substantia nigra and corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids , 2012, Front. Hum. Neurosci..

[33]  J. Terao,et al.  Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. , 2011, Free radical biology & medicine.

[34]  N. Mitra,et al.  Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum , 2011, Neuroscience Letters.

[35]  Victor Tapias,et al.  A highly reproducible rotenone model of Parkinson's disease , 2009, Neurobiology of Disease.

[36]  Qin Wu,et al.  Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. , 2008, European journal of pharmacology.

[37]  F. Salta,et al.  Currants (Vitis vinifera L.) content of simple phenolics and antioxidant activity , 2007 .

[38]  F. Fumagalli,et al.  Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease , 2006, The Pharmacogenomics Journal.

[39]  J. O’Keefe,et al.  Rearing on Hind Legs, Environmental Novelty, and the Hippocampal Formation , 2006, Reviews in the neurosciences.

[40]  S. Kallithraka,et al.  Determination of major anthocyanin pigments in Hellenic native grape varieties (Vitis vinifera sp.): association with antiradical activity , 2005 .

[41]  P. Agostinho,et al.  Neurodegenerative pathways in Parkinson's disease: therapeutic strategies. , 2005, Current drug targets. CNS and neurological disorders.

[42]  N. Matsokis,et al.  Thiol redox state and oxidative stress in midbrain and striatum of weaver mutant mice, a genetic model of nigrostriatal dopamine deficiency , 2005, Neuroscience Letters.

[43]  Todd B. Sherer,et al.  Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.

[44]  A. Aro,et al.  Consumption of black currants, lingonberries and bilberries increases serum quercetin concentrations , 2003, European Journal of Clinical Nutrition.

[45]  Wim E Crusio.  Genetic dissection of mouse exploratory behaviour , 2001, Behavioural Brain Research.

[46]  P. Bose,et al.  Phenol antioxidant quantity and quality in foods: fruits. , 2001, Journal of agricultural and food chemistry.

[47]  E. Hirsch,et al.  Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. , 1999, Neuroreport.

[48]  P. Jenner,et al.  Understanding cell death in parkinson's disease , 1998, Annals of neurology.

[49]  G. Yancopoulos,et al.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra , 1991, Nature.

[50]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .